BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olgasi C, Talmon M, Merlin S, Cucci A, Richaud-Patin Y, Ranaldo G, Colangelo D, Di Scipio F, Berta GN, Borsotti C, Valeri F, Faraldi F, Prat M, Messina M, Schinco P, Lombardo A, Raya A, Follenzi A. Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A. Stem Cell Reports 2018;11:1391-406. [PMID: 30416049 DOI: 10.1016/j.stemcr.2018.10.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Son JS, Park C, Lee G, Park JY, Kim HJ, Kim G, Chi KY, Woo D, Han C, Kim SK, Park H, Kim D, Kim J. Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121429] [Reference Citation Analysis]
2 Fus-Kujawa A, Mendrek B, Trybus A, Bajdak-Rusinek K, Stepien KL, Sieron AL. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives. Biomolecules 2021;11:699. [PMID: 34067183 DOI: 10.3390/biom11050699] [Reference Citation Analysis]
3 Rodríguez-Merchán EC, De Pablo-Moreno JA, Liras A. Gene Therapy in Hemophilia: Recent Advances. Int J Mol Sci 2021;22:7647. [PMID: 34299267 DOI: 10.3390/ijms22147647] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ebrahimi M, Forouzesh M, Raoufi S, Ramazii M, Ghaedrahmati F, Farzaneh M. Differentiation of human induced pluripotent stem cells into erythroid cells. Stem Cell Res Ther 2020;11:483. [PMID: 33198819 DOI: 10.1186/s13287-020-01998-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhou M, Hu Z, Zhang C, Wu L, Li Z, Liang D. Gene Therapy for Hemophilia A: Where We Stand. Curr Gene Ther 2020;20:142-51. [PMID: 32767930 DOI: 10.2174/1566523220666200806110849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gong J, Wang HL, Chang LJ. Molecular therapeutics of Hemophilia A and B. Expert Rev Hematol 2022. [PMID: 35523283 DOI: 10.1080/17474086.2022.2075339] [Reference Citation Analysis]
7 Gage BK, Merlin S, Olgasi C, Follenzi A, Keller GM. Therapeutic correction of hemophilia A by transplantation of hPSC-derived liver sinusoidal endothelial cell progenitors. Cell Rep 2022;39:110621. [PMID: 35385743 DOI: 10.1016/j.celrep.2022.110621] [Reference Citation Analysis]
8 Rao I, Crisafulli L, Paulis M, Ficara F. Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders. Cells 2022;11:557. [DOI: 10.3390/cells11030557] [Reference Citation Analysis]
9 Aboul-Soud MAM, Alzahrani AJ, Mahmoud A. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening. Cells 2021;10:2319. [PMID: 34571968 DOI: 10.3390/cells10092319] [Reference Citation Analysis]
10 Viswanathan P, Sharma Y, Jaber FL, Tchaikovskaya T, Gupta S. Transplanted hepatocytes rescue mice in acetaminophen-induced acute liver failure through paracrine signals for hepatic ATM and STAT3 pathways. FASEB J 2021;35:e21471. [PMID: 33683737 DOI: 10.1096/fj.202002421R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Olgasi C, Cucci A, Follenzi A. iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine. Int J Mol Sci 2020;21:E6215. [PMID: 32867371 DOI: 10.3390/ijms21176215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Neumeyer J, Lin RZ, Wang K, Hong X, Hua T, Croteau SE, Neufeld EJ, Melero-Martin JM. Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream. Blood Adv 2019;3:4166-76. [PMID: 31851760 DOI: 10.1182/bloodadvances.2019000848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
13 Lee J, Bayarsaikhan D, Bayarsaikhan G, Kim J, Schwarzbach E, Lee B. Recent advances in genome editing of stem cells for drug discovery and therapeutic application. Pharmacology & Therapeutics 2020;209:107501. [DOI: 10.1016/j.pharmthera.2020.107501] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
14 Rose M, Gao K, Cortez-Toledo E, Agu E, Hyllen AA, Conroy K, Pan G, Nolta JA, Wang A, Zhou P. Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A. Stem Cells Transl Med 2020;9:686-96. [PMID: 32162786 DOI: 10.1002/sctm.19-0261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
15 Georgomanoli M, Papapetrou EP. Modeling blood diseases with human induced pluripotent stem cells. Dis Model Mech 2019;12:dmm039321. [PMID: 31171568 DOI: 10.1242/dmm.039321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
16 Ryu YH, Moon SH, Kim KJ, Jun YJ, Oh DY, Kim SH, Rhie JW. A Novel Hypothesis and Characterization to Isolate Microvascular Endothelial Cells Simultaneously with Adipose-Derived Stem Cells from the Human Adipose-Derived Stromal Vascular Fraction. Tissue Eng Regen Med 2021;18:429-40. [PMID: 33877617 DOI: 10.1007/s13770-021-00332-5] [Reference Citation Analysis]
17 Jia W, Sharma D, He W, Xing Q, Zhao F. Preservation of microvascular integrity and immunomodulatory property of prevascularized human mesenchymal stem cell sheets. J Tissue Eng Regen Med 2021;15:207-18. [PMID: 33432700 DOI: 10.1002/term.3167] [Reference Citation Analysis]
18 Ewald ML, Chen YH, Lee AP, Hughes CCW. The vascular niche in next generation microphysiological systems. Lab Chip 2021;21:3244-62. [PMID: 34396383 DOI: 10.1039/d1lc00530h] [Reference Citation Analysis]
19 Chen Y, Yi Y, Xu J, Chan WK, Loh YH. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming. FEBS Lett 2019;593:3244-52. [PMID: 31691960 DOI: 10.1002/1873-3468.13659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Gage BK, Liu JC, Innes BT, MacParland SA, McGilvray ID, Bader GD, Keller GM. Generation of Functional Liver Sinusoidal Endothelial Cells from Human Pluripotent Stem-Cell-Derived Venous Angioblasts. Cell Stem Cell 2020;27:254-269.e9. [PMID: 32640183 DOI: 10.1016/j.stem.2020.06.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
21 Chaudhari N, Rickard AM, Roy S, Dröge P, Makhija H. A non-viral genome editing platform for site-specific insertion of large transgenes. Stem Cell Res Ther 2020;11:380. [PMID: 32883366 DOI: 10.1186/s13287-020-01890-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Famà R, Borroni E, Zanolini D, Merlin S, Bruscaggin V, Walker GE, Olgasi C, Babu D, Agnelli Giacchello J, Valeri F, Giordano M, Borchiellini A, Follenzi A. Identification and functional characterization of a novel splicing variant in the F8 coagulation gene causing severe hemophilia A. J Thromb Haemost 2020;18:1050-64. [PMID: 32078252 DOI: 10.1111/jth.14779] [Reference Citation Analysis]
23 Hayakawa M, Sakata A, Hayakawa H, Matsumoto H, Hiramoto T, Kashiwakura Y, Baatartsogt N, Fukushima N, Sakata Y, Suzuki-Inoue K, Ohmori T. Characterization and visualization of murine coagulation factor VIII-producing cells in vivo. Sci Rep 2021;11:14824. [PMID: 34290295 DOI: 10.1038/s41598-021-94307-0] [Reference Citation Analysis]
24 Wattanapanitch M. Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. Stem Cells Int. 2019;2019:5171032. [PMID: 31191673 DOI: 10.1155/2019/5171032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
25 Martorell L, Cortina V, Parra R, Barquinero J, Vidal F. Variable readthrough responsiveness of nonsense mutations in hemophilia A. Haematologica 2020;105:508-18. [PMID: 31197069 DOI: 10.3324/haematol.2018.212118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Jamil MA, Singer H, Al-Rifai R, Nüsgen N, Rath M, Strauss S, Andreou I, Oldenburg J, El-Maarri O. Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells. Int J Mol Sci 2020;21:E7776. [PMID: 33096636 DOI: 10.3390/ijms21207776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 El-Maarri O, Jamil MA, Oldenburg J. Molecular Profiling of Liver Sinusoidal Endothelial Cells in Comparison to Hepatocytes: Reflection on Which Cell Type Should Be the Target for Gene Therapy. Hamostaseologie 2020;40:S26-31. [PMID: 33187005 DOI: 10.1055/a-1282-2286] [Reference Citation Analysis]
28 Pratumkaew P, Issaragrisil S, Luanpitpong S. Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. Cells 2021;10:3250. [PMID: 34831472 DOI: 10.3390/cells10113250] [Reference Citation Analysis]